Modulation of Amyloid-β1–40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier-Reference-Cited by-同舟云学术

Modulation of Amyloid-β1–40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier

Published:2016-07-13 Issue:2 Volume:53 Page:677-691
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Merino-Zamorano Cristina¹,Fernández-de Retana Sofía¹,Montañola Alex¹,Batlle Aina¹,Saint-Pol Julien²,Mysiorek Caroline²,Gosselet Fabien²,Montaner Joan¹³,Hernández-Guillamon Mar¹

Affiliation:

1. Neurovascular Research Laboratory, Vall d’Hebron Research Insitute, Universitat Autònoma de Barcelona, Barcelona, Spain

2. Univ. Artois, EA2465, Laboratoire de la Barrière Hémato-Encéphalique, LBHE, Lens, F-62300, France

3. Department of Neurology, Neurovascular Unit, Vall d’Hebron Hospital, Barcelona, Spain

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference60 articles.

1. Cerebral amyloid angiopathy: An overview;Yamada;Neuropathology,2000

2. Sporadic cerebral amyloid angiopathy: Pathology, clinical implications, and possible pathomechanisms;Attems;Neuropathology,2005

3. Decreased clearance of CNS beta-amyloid in Alzheimer’s disease;Mawuenyega;Science,2010

4. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer’s disease;Bell;Acta Neuropathol,2009

5. Amyloid-β peptides, Alzheimer’s disease and the blood-brain barrier;Gosselet;Curr Alzheimer Res,2013

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of cerebrospinal fluid (CSF) and interstitial fluid (ISF) mouse proteomes for the validation and description of Alzheimer’s disease biomarkers;Journal of Neuroscience Methods;2024-11

2. The presence of circulating human apolipoprotein J reduces the occurrence of cerebral microbleeds in a transgenic mouse model with cerebral amyloid angiopathy;Alzheimer's Research & Therapy;2024-07-29

3. Methionine oxidation of clusterin in Alzheimer’s disease and its effect on clusterin’s binding to beta-amyloid;Neuroscience Letters;2024-07

4. Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii;Journal of Nanobiotechnology;2024-03-30

5. Cognitive Fitness: Harnessing the Strength of Exerkines for Aging and Metabolic Challenges;Sports;2024-02-13